Literature DB >> 22925720

Utility of rapid antibody tests to exclude HIV-1 infection among infants and children aged <18 months in a low-resource setting.

Ann M Buchanan1, Behzad Nadjm, Ben Amos, George Mtove, David Sifuna, Coleen K Cunningham, John A Crump, Hugh Reyburn.   

Abstract

BACKGROUND: Excluding HIV infection among infants and young children in resource-poor settings where nucleic acid amplification tests (NAAT) are not routinely available remains a considerable challenge.
OBJECTIVES: To assess the performance of two rapid HIV antibody tests (RT) used alone and in parallel for excluding HIV infection among acutely ill infants and children <18 months in comparison to NAAT in a region where maternal HIV prevalence was approximately 7%. STUDY
DESIGN: Infants and children ≥2<18 months admitted to hospital with an acute febrile illness had two rapid antibody tests in parallel, with single and parallel results subsequently compared against NAAT.
RESULTS: HIV prevalence among 1602 enrolled infants was 3.4%. All 1526 infants with 2 negative RT were HIV negative by NAAT. All 46 infants with 2 positive RT were HIV positive by NAAT. The overall specificity of two rapid tests for excluding HIV infection was 99.5%. Sensitivity and specificity were ≥99% and >98%, respectively, across all age brackets ≥2<18 months. Overall sensitivity and specificity for a single RT was 98.2% and 99%, respectively, for Determine, and 85.5% and 99.6%, respectively, for Capillus.
CONCLUSIONS: In a setting with a maternal HIV prevalence rate of <10%, a single negative RT had excellent specificity and two negative RT performed in parallel had a perfect negative predictive value for HIV infection among acutely ill patients <18 months of age. In this and similar settings, RT could assist with excluding HIV infection with much lower complexity and cost than NAAT.
Copyright © 2012 Elsevier B.V. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22925720      PMCID: PMC3449279          DOI: 10.1016/j.jcv.2012.08.001

Source DB:  PubMed          Journal:  J Clin Virol        ISSN: 1386-6532            Impact factor:   3.168


  22 in total

1.  Viral load and disease progression in infants infected with human immunodeficiency virus type 1. Women and Infants Transmission Study Group.

Authors:  W T Shearer; T C Quinn; P LaRussa; J F Lew; L Mofenson; S Almy; K Rich; E Handelsman; C Diaz; M Pagano; V Smeriglio; L A Kalish
Journal:  N Engl J Med       Date:  1997-05-08       Impact factor: 91.245

2.  Efficient IgG-mediated suppression of primary antibody responses in Fcgamma receptor-deficient mice.

Authors:  M C Karlsson; S Wernersson; T Diaz de Ståhl; S Gustavsson; B Heyman
Journal:  Proc Natl Acad Sci U S A       Date:  1999-03-02       Impact factor: 11.205

3.  Difficulties in assigning human immunodeficiency virus-1 infection and seroreversion status in a cohort of HIV-exposed in children using serologic criteria established by the Centers for Disease Control and Prevention.

Authors:  B J Simpson; W A Andiman
Journal:  Pediatrics       Date:  1994-05       Impact factor: 7.124

4.  Abbott RealTime HIV-1 m2000rt viral load testing: manual extraction versus the automated m2000sp extraction.

Authors:  Lesley E Scott; John A Crump; Emma Msuya; Anne B Morrissey; Willem F Venter; Wendy S Stevens
Journal:  J Virol Methods       Date:  2010-12-21       Impact factor: 2.014

5.  Clinical and epidemiologic features of primary HIV infection.

Authors:  T Schacker; A C Collier; J Hughes; T Shea; L Corey
Journal:  Ann Intern Med       Date:  1996-08-15       Impact factor: 25.391

6.  Comparison of the sensitivity of four rapid assays for the detection of antibodies to HIV-1/HIV-2 during seroconversion.

Authors:  H H Samdal; B G Gutigard; D Labay; S I Wiik; K Skaug; A G Skar
Journal:  Clin Diagn Virol       Date:  1996-10

7.  Dynamics of HIV viremia and antibody seroconversion in plasma donors: implications for diagnosis and staging of primary HIV infection.

Authors:  Eberhard W Fiebig; David J Wright; Bhupat D Rawal; Patricia E Garrett; Richard T Schumacher; Lorraine Peddada; Charles Heldebrant; Richard Smith; Andrew Conrad; Steven H Kleinman; Michael P Busch
Journal:  AIDS       Date:  2003-09-05       Impact factor: 4.177

8.  Predicting perinatal human immunodeficiency virus infection by antibody patterns.

Authors:  D Moodley; R A Bobat; A Coutsoudis; H M Coovadia
Journal:  Pediatr Infect Dis J       Date:  1995-10       Impact factor: 2.129

9.  Early prognostic indicators in primary perinatal human immunodeficiency virus type 1 infection: importance of viral RNA and the timing of transmission on long-term outcome.

Authors:  R E Dickover; M Dillon; K M Leung; P Krogstad; S Plaeger; S Kwok; C Christopherson; A Deveikis; M Keller; E R Stiehm; Y J Bryson
Journal:  J Infect Dis       Date:  1998-08       Impact factor: 5.226

10.  Seroreversion in human immunodeficiency virus-exposed but uninfected infants.

Authors:  C J Chantry; E R Cooper; S I Pelton; C Zorilla; G V Hillyer; C Diaz
Journal:  Pediatr Infect Dis J       Date:  1995-05       Impact factor: 2.129

View more
  1 in total

Review 1.  Point-of-care tests detecting HIV nucleic acids for diagnosis of HIV-1 or HIV-2 infection in infants and children aged 18 months or less.

Authors:  Eleanor A Ochodo; Fatuma Guleid; Jonathan J Deeks; Sue Mallett
Journal:  Cochrane Database Syst Rev       Date:  2021-08-12
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.